Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 oct. 2022 16h58 HE | Source: Hagens Berman Sobol Shapiro LLP

ABT DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

SAN FRANCISCO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19, 2021...
27 sept. 2022 14h01 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

SAN FRANCISCO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...
22 sept. 2022 13h08 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Fraud Class Action

SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...
17 sept. 2022 12h10 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

SAN FRANCISCO, Sept. 17, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...
12 sept. 2022 10h33 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

SAN FRANCISCO, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19, 2021...
07 sept. 2022 18h42 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Infant Formula-Related Securities Fraud Class Action Filed

SAN FRANCISCO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb....
02 sept. 2022 18h46 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Infant Formula-Related Securities Fraud Class Action Filed

SAN FRANCISCO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Abbott Laboratories (NYSE: ABT) investors who suffered significant losses to submit your losses now. Class Period: Feb. 19,...